Skip to main content
logo
Attovia Therapeutics, Inc. (ATTO)
NASDAQ: ATTO · Real-Time Price · USD
19.86
+0.68 (3.55%)
At close: Aug 14, 2026, 4:00 PM EDT
19.56
-0.30 (-1.51%)
After-hours: Aug 14, 2026, 7:34 PM EDT

Attovia Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Net Income
-64.13-60.63-39.8
Depreciation & Amortization
0.90.80.31
Other Amortization
0.030.39-
Loss (Gain) From Sale of Assets
00.010.01
Loss (Gain) From Sale of Investments
-2.52-2.66-0.68
Stock-Based Compensation
2.612.391.39
Other Operating Activities
0.190.222.2
Change in Accounts Payable
-0.120.181.72
Change in Other Net Operating Assets
-0.170.1-0.18
Operating Cash Flow
-63.21-59.2-35.04
Operating Cash Flow Growth
---

Investing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Capital Expenditures
-0.81-2.31-1.77
Investment in Securities
-20.87-71.14-38.03
Investing Cash Flow
-21.68-73.46-39.8

Financing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Long-Term Debt Repaid
---0.17
Net Debt Issued (Repaid)
---0.17
Issuance of Common Stock
0.160.190.31
Other Financing Activities
-1.28-0.38-0.02
Financing Cash Flow
-1.12142.0182.75

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Net Cash Flow
-86.019.367.91

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Free Cash Flow
-64.02-61.51-36.81
Free Cash Flow Growth
---
Free Cash Flow Margin
-4742.07%-4556.44%-
Free Cash Flow Per Share
-15.86-15.57-10.42
Levered Free Cash Flow
--40.21-
Unlevered Free Cash Flow
--40.6-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Change in Working Capital
-0.290.281.54
SEC Filings: 10-K · 10-Q